Literature DB >> 1728504

Sudden cardiac death in patients with chronic coronary heart disease.

J L Hurwitz1, M E Josephson.   

Abstract

Sudden cardiac death (SCD) is responsible for 300,000-400,000 deaths per year with a recurrence rate of up to 40% in survivors within the first 2 years. SCD often occurs in patients with chronic coronary artery disease, which is manifested by myocardial infarction and left ventricular dysfunction but is infrequently associated with acute infarction. SCD may be the initial symptom of coronary artery disease. Primary or rapid ventricular tachycardia are the most common arrhythmic causes of SCD. Endocardial mapping studies during electrophysiological study have shown areas of slowed conduction with abnormal endocardial electrograms in SCD patients with moderately damaged ventricles. SCD increases with age and occurs more frequently in men with coronary artery disease as a significant risk factor. Complex ventricular ectopy, once thought of as an independent risk factor, is not as good a predictor as poor left ventricular function for recurrence of SCD. While signal-averaged electrocardiograms can identify patients with slowed conduction, their positive predictive value for SCD is poor. Initial evaluation should be aimed at the identification of ischemia, since those patients with SCD and acute myocardial infarction do well when treated for their ischemia. The arrhythmias that are inducible during electrophysiological study are rapid and poorly tolerated. Patients with inducible ventricular tachycardia who are rendered noninducible pharmacologically have a good prognosis, whereas those who are still inducible or have no inducible arrhythmias have a high recurrence rate of SCD and should be considered for subendocardial resection when appropriate or for placement of an implantable defibrillator.

Entities:  

Mesh:

Year:  1992        PMID: 1728504

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  3 in total

1.  Scintigraphy of myocardial innervation with metaiodobenzylguanidine (MIBG): is there a clinical application?

Authors:  M W Dae
Journal:  J Nucl Cardiol       Date:  1995 Mar-Apr       Impact factor: 5.952

2.  Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy.

Authors:  Stephan Fluechter; Jürgen Kuschyk; Christian Wolpert; Christina Doesch; Christian Veltmann; Dariusch Haghi; Stefan O Schoenberg; Tim Sueselbeck; Tjeerd Germans; Florian Streitner; Martin Borggrefe; Theano Papavassiliu
Journal:  J Cardiovasc Magn Reson       Date:  2010-05-21       Impact factor: 5.364

Review 3.  The cardiac ventricular myocyte as a substrate for sudden death. The regional lecture in Bath 1993.

Authors:  G Hart
Journal:  J R Coll Physicians Lond       Date:  1993-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.